When compared with the differentiated cells of triple-negative breast cancer cells, the stemness-bearing CD44+CD24− cell population has a preferentially higher activity in the IL-6/JAK/STAT3 pathway, leading to CSC proliferation and tumor growth [47]. This evidence concerns the gene IL6 and neoplasm.